PIK3CA mutations are associated with increased tumor aggressiveness and Akt activation in gastric cancer.

about

Association between PIK3CA alteration and prognosis of gastric cancer patients: a meta-analysis.

P2860

Q50299737-02340737-BF15-40AF-80DB-948DB4EBA32F

P2860

PIK3CA mutations are associated with increased tumor aggressiveness and Akt activation in gastric cancer.

Item

http://www.wikidata.org/entity/Q47157362

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

PIK3CA mutations are associate ...... activation in gastric cancer.

@en

PIK3CA mutations are associate ...... activation in gastric cancer.

@nl

type

Item

label

PIK3CA mutations are associate ...... activation in gastric cancer.

@en

PIK3CA mutations are associate ...... activation in gastric cancer.

@nl

prefLabel

PIK3CA mutations are associate ...... activation in gastric cancer.

@en

PIK3CA mutations are associate ...... activation in gastric cancer.

@nl

P1476

PIK3CA mutations are associate ...... activation in gastric cancer.

@en

P2093

Do Joong Park

http://www.w3.org/2001/XMLSchema#string

Hyung-Ho Kim

http://www.w3.org/2001/XMLSchema#string

Ji-Won Kim

http://www.w3.org/2001/XMLSchema#string

Jin Won Kim

http://www.w3.org/2001/XMLSchema#string

Keun-Wook Lee

http://www.w3.org/2001/XMLSchema#string

Kyung Han Nam

http://www.w3.org/2001/XMLSchema#string

Sang-Hoon Ahn

http://www.w3.org/2001/XMLSchema#string

Soyeon Ahn

http://www.w3.org/2001/XMLSchema#string

P2860

Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability

A functional genetic approach identifies the PI3K pathway as a major determinant of trastuzumab resistance in breast cancer.

Highly frequent PIK3CA amplification is associated with poor prognosis in gastric cancer.

Phase II study of everolimus with biomarker exploration in patients with advanced gastric cancer refractory to chemotherapy including fluoropyrimidine and platinum

Global cancer statistics, 2012

High frequency of mutations of the PIK3CA gene in human cancers

Comprehensive molecular characterization of gastric adenocarcinoma

The phosphatidylinositol 3-Kinase AKT pathway in human cancer

Clinicopathological features and prognostic roles of KRAS, BRAF, PIK3CA and NRAS mutations in advanced gastric cancer.

The analysis of PIK3CA mutations in gastric carcinoma and metanalysis of literature suggest that exon-selectivity is a signature of cancer type.

P304

90948-90958

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.18770

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Hye Seung Lee

P577

2017-06-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29207615

http://www.w3.org/2001/XMLSchema#string

P932

5710896

http://www.w3.org/2001/XMLSchema#string

PIK3CA mutations are associated with increased tumor aggressiveness and Akt activation in gastric cancer.

about

P2860

P2860

PIK3CA mutations are associated with increased tumor aggressiveness and Akt activation in gastric cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932